Pila Pharma Danmark ApS: Financial statements 2024
CVR: 39023636
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Pila Pharma Danmark ApS (CVR 39023636) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -3,901,454 and a net result of DKK -3,094,589 compared with DKK -3,817,180 the year before. Equity in the 2024 report amounted to DKK 335,813. The solvency ratio was 15.8%.
- Gross Profit
- DKK -3,901,454
- Profit/Loss
- DKK -3,094,589
- Equity
- DKK 335,813
- Total Assets
- DKK 2,124,955
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -3.9M | -3.1M | 336K | 0 |
| 2023 | - | -4.4M | -3.8M | 1.4M | - |
| 2022 | - | -13.4M | -10.8M | 3M | - |
| 2021 | - | -6.4M | -5.1M | 1.3M | - |
| 2020 | - | -3.5M | -2.8M | 854K | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pila Pharma Danmark ApS has published its annual report for 2023. Gross profit came to DKK -4,374,351, and the net result was DKK -3,817,180.
About Pila Pharma Danmark ApS
Pila Pharma Danmark ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2017. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Dorte Xenia Gram. The company is owned by Pila Pharma AB. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -4,798,283 and a net result of DKK -3,780,896 compared with DKK -3,094,589 the year before. Equity in the 2025 report amounted to DKK 2,596,207.